Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Largecap Dividend Wisdomtree | DLN | Jan 15, 2025 | 78.63 | +1.24 |
Largecap ETF Vanguard | VV | Jan 15, 2025 | 273.06 | +1.80 |
Largecap Growth Opp Alphadex First Trust | FTC | Jan 15, 2025 | 140.84 | +1.27 |
Largecap Value Opp Alphadex First Trust | FTA | Jan 15, 2025 | 78.51 | +0.91 |
Largo | LGO | Jan 15, 2025 | 1.72 | +4.40 |
Larimar Therapeutics | LRMR | Jan 15, 2025 | 3.40 | +3.34 |
Las Vegas Sands | LVS | Jan 15, 2025 | 44.20 | -1.78 |
Laser Photonics | LASE | Jan 15, 2025 | 5.20 | +2.77 |
Latham Group | SWIM | Jan 15, 2025 | 6.61 | +4.92 |
Latin America Alphadex First Trust | FLN | Jan 15, 2025 | 15.80 | +2.66 |
Lattice Semiconductor | LSCC | Jan 15, 2025 | 57.28 | +3.39 |
Launch One Acquisition | LPAA | Jan 15, 2025 | 10.07 | +0.10 |
Launch One Acquisition | LPAAU | Jan 15, 2025 | 10.12 | -0.10 |
Launch Two Acquisition A | LPBB | Jan 15, 2025 | 9.96 | 0.00 |
Launch Two Acquisition Units | LPBBU | Jan 15, 2025 | 10.16 | 0.00 |
Laureate Education | LAUR | Jan 15, 2025 | 18.82 | +2.45 |
LAVA Therapeutics | LVTX | Jan 15, 2025 | 0.97 | -1.02 |
Lavoro | LVRO | Jan 15, 2025 | 3.49 | -7.92 |
Lazard A | LAZ | Jan 15, 2025 | 49.73 | +6.06 |
Lazard Global Total Return and Income Fund | LGI | Jan 15, 2025 | 15.96 | +1.46 |
Lazydays | GORV | Jan 15, 2025 | 0.78 | -1.20 |
LCI Industries | LCII | Jan 15, 2025 | 105.81 | +3.85 |
LCNB | LCNB | Jan 15, 2025 | 15.17 | +1.95 |
Lead Real Estate ADR | LRE | Jan 15, 2025 | 1.86 | -9.54 |
Leafly | LFLY | Jan 15, 2025 | 1.44 | +2.13 |
Leap Therapeutics | LPTX | Jan 15, 2025 | 3.25 | +5.18 |
Lear | LEA | Jan 15, 2025 | 94.18 | +0.72 |
LeddarTech | LDTC | Jan 15, 2025 | 1.25 | +17.92 |
Lee Enterprises | LEE | Jan 15, 2025 | 13.07 | +0.77 |
Legacy Housing | LEGH | Jan 15, 2025 | 24.34 | +2.83 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.